CURE’s gastric cancer page is a go-to resource for oncology news and updates in the world of gastric cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in gastric cancer.
September 19th 2024
In patients with BRAF V600E-mutant metastatic colorectal cancer, a combination of Braftovi, Erbitux and chemotherapy showed promising antitumor activity.
September 16th 2024
September 14th 2024
FDA Approves Onivyde as First-Line Treatment of Metastatic Pancreatic Cancer
February 13th 2024The Food and Drug Administration has approved Onivyde with oxaliplatin, fluorouracil and leucovorin, for the first-line treatment of patients with metastatic pancreatic adenocarcinoma, the agency has announced.
Fruzaqla Delays Colorectal Cancer Progression, Prolongs Patient Survival
January 23rd 2024Findings presented at the 2024 Gastrointestinal Cancers Symposium support Fruzaqla’s potential to provide an improved survival benefit and quality of life for those with previously treated metastatic colorectal cancer.
FDA Approves Fruzaqla for Previously Treated Metastatic Colorectal Cancer
November 9th 2023Patients with metastatic colorectal cancer are eligible for treatment with Fruzaqla, an oral targeted therapy, following treatment via fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy as well as an anti-VEGF therapy, and, if their disease RAS wild-type and medically appropriate, an anti-EGFR therapy.
Keytruda Plus Herceptin, Chemo Boosts PFS in HER2+ Gastric/GEJ Cancer
October 28th 2023Keytruda plus the combination of Herceptin and chemotherapy led to an improvement in progression-free survival versus placebo plus Herceptin and chemotherapy in the first-line treatment of some patients with metastatic HER2-positive gastric or gastroesophageal junction cancer.